<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Share</title>
	<atom:link href="http://www.tapanray.in/tag/share/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Expand Market Share Unleashing Digital Health Potential For All</title>
		<link>http://www.tapanray.in/expand-market-share-unleashing-digital-health-potential-for-all/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=expand-market-share-unleashing-digital-health-potential-for-all</link>
		<comments>http://www.tapanray.in/expand-market-share-unleashing-digital-health-potential-for-all/#comments</comments>
		<pubDate>Mon, 15 Nov 2021 00:00:34 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[adoption]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[channel]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[equity]]></category>
		<category><![CDATA[expand]]></category>
		<category><![CDATA[governance]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inequity]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[marketers]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[platform]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Share]]></category>
		<category><![CDATA[speedy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10609</guid>
		<description><![CDATA[“Advancement in digital health is currently restricted mainly to economically and socially privileged populations. Those having access, resources and basic digital skills, are reaping disproportionate benefits from the technology and other associated infrastructure available for this purpose. Unfortunately, underserved population, &#8230; <a href="http://www.tapanray.in/expand-market-share-unleashing-digital-health-potential-for-all/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/expand-market-share-unleashing-digital-health-potential-for-all/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Changing &#8211; The Key Differentiator To Boost Pharma Market Share</title>
		<link>http://www.tapanray.in/changing-the-key-differentiator-to-boost-pharma-market-share/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=changing-the-key-differentiator-to-boost-pharma-market-share</link>
		<comments>http://www.tapanray.in/changing-the-key-differentiator-to-boost-pharma-market-share/#comments</comments>
		<pubDate>Mon, 08 Jul 2019 00:00:27 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Awards]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[breathe of life]]></category>
		<category><![CDATA[Cannes]]></category>
		<category><![CDATA[changing]]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[creative]]></category>
		<category><![CDATA[differentiator]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Lions]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[offerings]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[problem]]></category>
		<category><![CDATA[Problem-solving]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[product-centric]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Share]]></category>
		<category><![CDATA[solution-centric]]></category>
		<category><![CDATA[solving]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Ways]]></category>
		<category><![CDATA[wellness]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9622</guid>
		<description><![CDATA[Health problems, affecting populations of any country, are many. So are the issues related to the delivery of effective health care solution, that most patients would consider satisfying and meaningful. From this perspective, prevention, treatment and effectively managing any disease &#8230; <a href="http://www.tapanray.in/changing-the-key-differentiator-to-boost-pharma-market-share/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/changing-the-key-differentiator-to-boost-pharma-market-share/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘Data-giri’: Critical For A Rewarding New Product Launch</title>
		<link>http://www.tapanray.in/data-giri-critical-for-a-rewarding-new-product-launch/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=data-giri-critical-for-a-rewarding-new-product-launch</link>
		<comments>http://www.tapanray.in/data-giri-critical-for-a-rewarding-new-product-launch/#comments</comments>
		<pubDate>Mon, 24 Dec 2018 00:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[(UCE)]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[Data-giri]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[launch]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[plan]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Share]]></category>
		<category><![CDATA[SOC]]></category>
		<category><![CDATA[SOV]]></category>
		<category><![CDATA[Strategic]]></category>
		<category><![CDATA[switch]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[unique]]></category>
		<category><![CDATA[UPE]]></category>
		<category><![CDATA[Voice]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9326</guid>
		<description><![CDATA[Success in new product launches is a fundamental requirement to excel in pharma business – regardless of whether the drug is innovative or a generic one. For a novel, innovative molecule, associated risks are much higher, as it carries a &#8230; <a href="http://www.tapanray.in/data-giri-critical-for-a-rewarding-new-product-launch/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/data-giri-critical-for-a-rewarding-new-product-launch/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
